Neurohypophysial hormones
2003; American Physiological Society; Volume: 285; Issue: 4 Linguagem: Inglês
10.1152/ajpregu.00390.2003
ISSN1522-1490
Autores Tópico(s)Circadian rhythm and melatonin
ResumoIN FOCUSNeurohypophysial hormonesThomas E. LohmeierThomas E. LohmeierDepartment of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi 39216Published Online:01 Oct 2003https://doi.org/10.1152/ajpregu.00390.2003MoreSectionsPDF (42 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInEmailWeChat the actions of antidiuretic hormone or vasopressin (AVP) to promote water retention and to acutely increase arterial pressure are well established. Oxytocin (OT) has well known effects on uterine contraction and milk ejection. In addition to these widely recognized hormonal actions, these peptides have additional behavioral, autonomic, renal, and cardiovascular effects, the physiological significance of which has been a topic of considerable interest to the authors contributing to this journal.AVP is a potent vasoconstrictor, but it is also capable of producing vasodilation. The vasoconstrictor effects of AVP are mediated via activation of V1 receptors; V2 receptors mediate the vasodilatory effects of the hormone, as well as its antidiuretic actions. Usually, the vasoconstrictor effects of AVP predominate, which is the basis for its role in the acute regulation of arterial pressure. For example, infant rats respond to moderate cold exposure with increased heat production by brown adipose tissue (5). However, at greater thermal challenges, thermogenesis can no longer compensate for heat loss, leading to substantial bodily cooling and bradycardia. In response to the resultant decrease in cardiac output, maintenance of arterial pressure is dependent on an increase in peripheral resistance, which is due, in part, to the vasoconstrictor effects of AVP (5). An impaired vasoconstrictor response to AVP appears to contribute to systemic vasodilation and hypotension in septic shock (6). In septic shock, the diminished vasoconstrictor response to AVP is due to downregulation of V1 receptors, a response that is likely mediated by proinflammatory cytokines. The vasodilatory effects of AVP are most readily exposed after V1 receptor antagonist administration, particularly when sympathetic reflexes are impaired. After V1 receptor blockade, incremental infusions of AVP caused progressive and comparable reductions in peripheral resistance in normal and quadriplegic subjects (9). However, arterial pressure decreased only in the latter, despite much larger compensatory increases in PRA, because of deficient reflex-mediated increments in cardiac output. At least in rats, hypotension stimulates the secretion of OT, as well as AVP. During hypotension, OT contributes to the maintenance of arterial pressure by stimulating renin release (15).Both AVP and OT have actions at the central nervous system that impact cardiovascular function. These actions are a result of the secretion of these peptides from oxytocinergic and vasopressinergic projections within the nervous system, as well as the secretion of these neurohypophysial hormones from magnocellular neurons, which, via the circulation, activate receptors at circumventricular organs. OT projections from parvocellular neurons of the paraventricular nucleus (PVN) to the solitary vagal complex are involved in the restraint of exercise-induced tachycardia and facilitate baroreflex-mediated bradycardia in response to increased arterial pressure (14). OT released at the lumbosacral spinal cord by descending projections from the parvocellular PVN activates proerectile neurons and, therefore, plays a role in reproductive function (12). The central actions of AVP (V1 receptor response) account for postexercise reductions in arterial pressure and heart rate, possibly by enhancing baroreflex function by activating receptors in the area postrema that project to the nucleus of the solitary tract (8). AVP is also released during stress and contributes, along with corticotropin-releasing hormone (CRH), to increased ACTH secretion (17). This presumably occurs in two ways. First, the AVP that is coreleased with CRH into the primary capillaries of the portal circulation in the stalk-median eminence region directly stimulates ACTH producing anterior pituitary cells. Second, the circulating AVP secreted from magnocellular neurons acts at the hypothalamus to increase the synthesis and release of CRH.There has been considerable interest in the neurohormonal mechanisms that influence salt appetite (1, 10, 24, 25, 29). The diversity of experimental models (e.g., adrenalectomy, dietary sodium deprivation, hypovolemia, fluid deprivation) used to evoke salt appetite undoubtedly results in different alterations in body fluid volumes, blood pressure, and neurohormonal responses, all of which must be carefully considered in the interpretation of experimental findings. In rats purportedly sodium depleted by administration of furosemide and DOCA, central administration of an antagonist to the AVP-V1 (but not the AVP-V2) receptor suppressed salt appetite, implicating a central role for this peptide in stimulating salt intake (10). In contrast, Schoorlemmer et al. (25) concluded that circulating ANG II, but not circulating AVP, accounts for most of the sodium appetite in adrenalectomized rats. In another study, mice in which the gene for OT had been deleted were given the choice between hypertonic saline and tap water after overnight fluid deprivation (1). Compared with wild-type, OT-deficient mice ingested considerably greater amounts of saline, supporting an inhibitory role for OT in the control of sodium appetite in this model. Further support for an inhibitory role of OT in salt appetite was provided by Roesch et al. (24), who were cognizant of the fact that OT limits the central actions of ANG II to increase sodium intake. Their findings indicate that the synergistic effects of mineralocorticoids on ANG II-induced salt intake are a result of the former attenuating the stimulatory effects of ANG II on the activation of inhibitory OT neurons.The antidiuretic effects of AVP and the role of AVP in osmoregulation continue to be important topics relating to neurohypophysial hormone function (2, 3, 11, 23, 26). To determine if the neuroendocrine link between volume sensing and renal function is preserved in compensated heart failure, Gabrielsen et al. (11) determined the renal excretory response to intravascular and central blood volume expansion by water immersion. Compared with control subjects, patients with compensated heart failure and an activated reninangiotensin system had a diminished natriuretic and diuretic response to water immersion. A less predictable finding, however, was that free water clearance was impaired in patients with heart failure, despite normal values for plasma AVP concentration. The transition from the seated to the head-down tilted position increases central blood volume and reflexly promotes salt and water excretion. Therefore, investigators from these same laboratories determined whether prolonged head-down bed rest leads to hypovolemia, activation of antinatriuretic mechanisms, and attenuation of the natriuretic response to acute saline loading (3). The impetus for this study was to determine whether this change in posture would serve as a model to study fluid regulation to weightlessness in space. Unfortunately, this did not prove to be the case. Although prolonged head-down bed rest did lead to a sustained reduction in body fluid volume and activation of the renin-angiotensin system, for reasons that were unclear it did not result in an attenuated natriuretic response to an acute saline load. Another unexpected finding was that chronic bed rest resulted in a reduction, not an increase, in plasma AVP concentration. Because central blood volume was chronically reduced and plasma osmolality increased, responses expected to increase AVP secretion, the authors speculated that suppression of AVP secretion was a result of either increased carotid sinus pressure or increased arterial pulse pressure. As activation of arterial baroreceptors inhibits AVP secretion, this contention is consistent with recent findings indicating that arterial baroreflexes do not completely reset when arterial pressure is chronically elevated (19). In northern elephant seal pups, the secretion of AVP is regulated by both volume (pressure) and osmolality (23). Furthermore, AVP appears to play an important role in promoting antidiuresis during their postweaning fasts of up to 12 wk in duration.Recent studies have provided a more complete understanding of the multiple factors and central mechanisms that influence AVP and OT secretion. Whereas cerebral osmoreceptors located in the forebrain are known to mediate osmotically induced changes in AVP and OT secretion, studies in rats given gastric salt loads are consistent with the notion that hepatic portal osmoreceptors as well stimulate neurohypophysial hormone secretion (28). Activation of this feedforward mechanism for hormone secretion precedes significant salt absorption into the general circulation and its detection by cerebral osmoreceptors. AVP secretion and nausea are induced by high doses of the gut hormone CCK after activation of gastrointestinal vagal afferent inputs to the nucleus of the solitary tract (4). ANG II also stimulates AVP secretion, and receptors for ANG II are present in the PVN and supraoptic nucleus (SON), as well as in brain regions that are osmosensitive (20). That the link between ANG II and AVP secretion may be physiologically relevant is supported by the observation that AVP secretion is impaired in dehydrated mice lacking the ANG AT1a receptor (20). Although there is a lower osmotic threshold for AVP secretion when plasma estrogen and progesterone are elevated, such as during the luteal phase of the menstrual cycle, progesterone does not affect osmotic AVP regulation through a mechanism independent of estrogen (7).The central nervous system pathways and the neurotransmitters responsible for regulating AVP secretion in response to various stimuli are incompletely resolved. The perinuclear zone surrounds the SON and is a major source of the inhibitory neurotransmitter GABA, which is present in many synaptic contacts in this nucleus. As lesions of the perinuclear zone attenuate the inhibition of SON AVP neurons induced by activation of both arterial and cardiopulmonary baroreceptors, it would appear that this region is an essential component of the pathway mediating nonosmotic secretion of AVP (13). Nitric oxide also inhibits AVP and OT secretion, and neural nitric oxide is expressed in both the SON and PVN, where it is colocalized with AVP and OT synthesizing neurons. Electrophysiological recordings from the SON indicate that nitric oxide inhibits AVP and OT neurons by potentiating GABAergic synaptic activity at this nucleus (27). The secretion of AVP and OT is stimulated by a number of different excitatory neurotransmitters with synaptic inputs into the SON (16, 18, 21, 22). One of the most important neurotransmitters that increases the excitability of the neurons in the SON is glutamate. The glutamate receptor subtypes that elicit AVP and OT secretion and mediate the hormonal response to an osmotic stimulus have been characterized by Sladek and coworkers (21, 22) using an explant of the hypothalamo-neurohypophysial system. References 1 Amico JA, Morris M, and Vollmer RR. Mice deficient in oxytocin manifest increased saline consumption following overnight fluid deprivation. Am J Physiol Regul Integr Comp Physiol 281: R1368-R1373, 2001.Link | ISI | Google Scholar2 Andersen LJ, Andersen JL, Pump B, and Bie P. Natriuresis induced by mild hypernatremia in humans. Am J Physiol Regul Integr Comp Physiol 282: R1754-R1761, 2002.Link | ISI | Google Scholar3 Bestle MH, Norsk P, and Bie P. Fluid volume and osmoregulation in humans after a week of head-down bed rest. Am J Physiol Regul Integr Comp Physiol 281: R310-R317, 2001.Link | ISI | Google Scholar4 Billig I, Yates BJ, and Rinaman L. Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin. Am J Physiol Regul Integr Comp Physiol 281: R1243-R1255, 2001.Link | ISI | Google Scholar5 Blumberg MS, Knoot TG, and Kirby RF. Neural and hormonal control of arterial pressure during cold exposure in unanesthetized week-old rats. Am J Physiol Regul Integr Comp Physiol 281: R1514-R1521, 2001.Link | ISI | Google Scholar6 Bucher M, Hobbhahn J, Taeger K, and Kurtz A. Cytokine-mediated downregulation of vasopressin V1A receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol 282: R979-R984, 2002.Link | ISI | Google Scholar7 Calzone WL, Silva C, Keefe DL, and Stachenfeld NS. Progesterone does not alter osmotic regulation of AVP. Am J Physiol Regul Integr Comp Physiol 281: R2011-R2020, 2001.Link | ISI | Google Scholar8 Collins HL, Rodenbaugh DW, and DiCarlo SE. Central blockade of vasopressin V1 receptors attenuates postexercise hypotension. Am J Physiol Regul Integr Comp Physiol 281: R375-R380, 2001.Link | ISI | Google Scholar9 Cooke CR, Wall BM, Huch KM, and Mangold T. Cardiovascular effects of vasopressin following V1 receptor blockade compared to effects of nitroglycerin. Am J Physiol Regul Integr Comp Physiol 281: R887-R893, 2001.Crossref | PubMed | ISI | Google Scholar10 Flynn FW, Kirchner TR, and Clinton ME. Brain vasopressin and sodium appetite. Am J Physiol Regul Integr Comp Physiol 282: R1236-R1244, 2002.Link | ISI | Google Scholar11 Gabrielsen A, Bie P, Holstein-Rathlou NH, Christensen NJ, Warberg J, Dige-Petersen H, Frandsen E, Galatius S, Pump B, Sorensen VB, Kastrup J, and Norsk P. Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 281: R459-R467, 2001.Link | ISI | Google Scholar12 Giuliano F, Bernabe J, McKenna K, Longueville F, and Rampin O. Spinal proerectile effect of oxytocin in anesthetized rats. Am J Physiol Regul Integr Comp Physiol 280: R1870-R1877, 2001.Link | ISI | Google Scholar13 Grindstaff RR and Cunningham JT. Lesion of the perinuclear zone attenuates cardiac sensitivity of vasopressinergic supraoptic neurons. Am J Physiol Regul Integr Comp Physiol 280: R630-R638, 2001.Link | ISI | Google Scholar14 Higa KT, Mori E, Viana FF, Morris M, and Michelini LC. Baroreflex control of heart rate by oxytocin in the solitary-vagal complex. Am J Physiol Regul Integr Comp Physiol 282: R537-R545, 2002.Link | ISI | Google Scholar15 Huang W, Sjoquist M, Skott O, Stricker EM, and Sved AF. Oxytocin antagonist disrupts hypotension evoked renin secretion and other responses in conscious rats. Am J Physiol Regul Integr Comp Physiol 280: R760-R765, 2001.Link | ISI | Google Scholar16 Kapoor JR and Sladek CD. Substance P and NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release. Am J Physiol Regul Integr Comp Physiol 280: R69-R78, 2001.Link | ISI | Google Scholar17 Laszlo FA, Varga C, Pavo I, Gardi J, Vecsernyes M, Galfi M, Morschl E, Laszlo F, and Makara GB. Vasopressin pressor receptor-mediated activation of HPA axis by acute ethanol stress in rats. Am J Physiol Regul Integr Comp Physiol 280: R458-R465, 2001.Link | ISI | Google Scholar18 Li DP and Pan HL. Potentiation of glutamatergic synaptic input to supraoptic neurons by presynaptic nicotinic receptors. Am J Physiol Regul Integr Comp Physiol 281: R1105-R1113, 2001.Link | ISI | Google Scholar19 Lohmeier TE, Lohmeier JR, Reckelhoff JF, and Hilde-brandt DA. Sustained influence of the renal nerves to attenuate sodium retention in angiotensin hypertension. Am J Physiol Regul Integr Comp Physiol 281: R434-R443, 2001.Link | ISI | Google Scholar20 Morris M, Means S, Oliverio MI, and Coffman TM. Enhanced central response to dehydration in mice lacking angiotensin AT1a receptors. Am J Physiol Regul Integr Comp Physiol 280: R1177-R1184, 2001.Link | ISI | Google Scholar21 Morsette DJ, Sidorowicz H, and Sladek CD. Role of metabotropic glutamate receptors in vasopressin and oxytocin release. Am J Physiol Regul Integr Comp Physiol 281: R452-R458, 2001.Link | ISI | Google Scholar22 Morsette DJ, Sidorowicz H, and Sladek CD. Role of non-NMDA receptors in vasopressin and oxytocin release from rat hypothalamo-neurohypophysial explants. Am J Physiol Regul Integr Comp Physiol 280: R313-R322, 2001.Link | ISI | Google Scholar23 Ortiz RM, Wade CE, Costa DP, and Ortiz CL. Renal responses to plasma volume expansion and hyperosmolality in fasting seal pups. Am J Physiol Regul Integr Comp Physiol 282: R805-R817, 2002.Link | ISI | Google Scholar24 Roesch DM, Blackburn-Munro RE, and Verbalis JG. Mineralocorticoid treatment attenuates activation of oxytocinergic and vasopressinergic neurons by icv ANG II. Am J Physiol Regul Integr Comp Physiol 280: R1853-R1864, 2001.Link | ISI | Google Scholar25 Schoorlemmer GHM, Johnson AK, and Thunhorst RL. Circulating angiotensin II mediates sodium appetite in adrenalectomized rats. Am J Physiol Regul Integr Comp Physiol 281: R723-R729, 2001.Link | ISI | Google Scholar26 Scrogin KE, McKeogh DF, and Brooks VL. Is osmolality a long-term regulator of renal sympathetic nerve activity in conscious water-deprived rats? Am J Physiol Regul Integr Comp Physiol 282: R560-R568, 2002.Link | ISI | Google Scholar27 Stern JE and Ludwig M. NO inhibits supraoptic oxytocin and vasopressin neurons via activation of GABAergic synaptic inputs. Am J Physiol Regul Integr Comp Physiol 280: R1815-R1822, 2001.Link | ISI | Google Scholar28 Stricker EM, Callahan JB, Huang W, and Sved AF. Early osmoregulatory stimulation of neurohypophyseal hormone secretion and thirst after gastric NaCl loads. Am J Physiol Regul Integr Comp Physiol 282: R1710-R1717, 2002.Link | ISI | Google Scholar29 Stricker EM, Craver CF, Curtis KS, Peacock-Kinzig KA, Sved AF, and Smith JC. Osmoregulation in water-deprived rats drinking hypertonic saline: effect of area postrema lesions. Am J Physiol Regul Integr Comp Physiol 280: R831-R842, 2001.Link | ISI | Google ScholarAUTHOR NOTES Address for reprint requests and other correspondence: T. E. Lohmeier, Univ. of Mississippi Medical Center, 2500 North State St., Jackson, MS 39216-4505 (E-mail: [email protected]). Download PDF Previous Back to Top Next FiguresReferencesRelatedInformationCited ByDiseases of the endocrine systemMicroRNA profiling in the mouse hypothalamus reveals oxytocin-regulating microRNA11 June 2013 | Journal of Neurochemistry, Vol. 126, No. 3Cardiac effects of oxytocin: Is there a role for this peptide in cardiovascular homeostasis?Regulatory Peptides, Vol. 132, No. 1-3Distinct rat neurohypophysial nerve terminal populations identified by size, electrophysiological properties and neuropeptide contentBrain Research, Vol. 1024, No. 1-2 More from this issue > Volume 285Issue 4October 2003Pages R715-R717 Copyright & PermissionsCopyright © 2003 the American Physiological Societyhttps://doi.org/10.1152/ajpregu.00390.2003PubMed12959914History Published online 1 October 2003 Published in print 1 October 2003 Metrics
Referência(s)